{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T22:24:11Z","timestamp":1771367051033,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,15]],"date-time":"2021-07-15T00:00:00Z","timestamp":1626307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010619","name":"University of Ottawa Heart Institute Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.hroo.2021.07.005","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T06:14:26Z","timestamp":1626761666000},"page":"412-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Management of ventricular tachycardia in patients with cardiac sarcoidosis"],"prefix":"10.1016","volume":"2","author":[{"given":"Mtwesi","family":"Viwe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Nery","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David H.","family":"Birnie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2021.07.005_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1365-2796.2011.02396.x","article-title":"Diagnosing isolated cardiac sarcoidosis","volume":"270","author":"Kandolin","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/j.hroo.2021.07.005_bib2","first-page":"364","article-title":"Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia","author":"Nery","year":"2013","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib3","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/jce.12401","article-title":"Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults","volume":"25","author":"Nery","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib4","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.amjcard.2015.08.025","article-title":"F-18-fluorodeoxyglucose positron emission tomography-guided sampling of mediastinal lymph nodes in the diagnosis of cardiac sarcoidosis","volume":"116","author":"Simonen","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib5","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.07.005_bib6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ijcard.2017.09.204","article-title":"How common is isolated cardiac sarcoidosis? Extra-cardiac and cardiac findings on clinical examination and whole-body (18)F-fluorodeoxyglucose positron emission tomography","volume":"253","author":"Juneau","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib7","first-page":"372","article-title":"Pathological studies on sarcoidosis autopsy. I. Epidemiological features of 320 cases in Japan","volume":"43","author":"Iwai","year":"1993","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.hroo.2021.07.005_bib8","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcmg.2016.05.009","article-title":"Prognostic value of myocardial scarring on CMR in patients with cardiac sarcoidosis","volume":"10","author":"Coleman","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2021.07.005_bib9","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1161\/CIRCULATIONAHA.115.016258","article-title":"Letter by Al-Kindi and Oliveira regarding article \"cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study.\"","volume":"132","author":"Al-Kindi","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.07.005_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCEP.110.959254","article-title":"Cardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adults","volume":"4","author":"Kandolin","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib11","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1016\/j.hrthm.2015.08.014","article-title":"Incidence of abnormal positron emission tomography in patients with unexplained cardiomyopathy and ventricular arrhythmias: the potential role of occult inflammation in arrhythmogenesis","volume":"12","author":"Tung","year":"2015","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.07.005_bib12","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.07.005_bib13","first-page":"19","article-title":"The WASOG Sarcoidosis Organ Assessment Instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.hroo.2021.07.005_bib14","first-page":"89","article-title":"Diagnostic standard and guidelines for sarcoidosis","volume":"27","year":"2007","journal-title":"Jpn J Sarcoidosis Granulomatous Disord"},{"key":"10.1016\/j.hroo.2021.07.005_bib15","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.hroo.2021.07.005_bib16","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.chest.2016.08.1457","article-title":"Cardiac sarcoidosis: the impact of age and implanted devices on survival","volume":"151","author":"Zhou","year":"2017","journal-title":"Chest"},{"key":"10.1016\/j.hroo.2021.07.005_bib17","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.acvd.2016.12.014","article-title":"Cardiac sarcoidosis: diagnosis, therapeutic management and prognostic factors","volume":"110","author":"Chapelon-Abric","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.hroo.2021.07.005_bib18","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1378\/chest.124.1.367","article-title":"What is sarcoidosis?","volume":"124","author":"Reich","year":"2003","journal-title":"Chest"},{"key":"10.1016\/j.hroo.2021.07.005_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.hrthm.2008.10.039","article-title":"Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry","volume":"6","author":"Jefic","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.07.005_bib20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.hrthm.2006.03.031","article-title":"Refractory ventricular tachycardia secondary to cardiac sarcoid: electrophysiologic characteristics, mapping, and ablation","volume":"3","author":"Koplan","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.07.005_bib21","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/clc.4960270409","article-title":"Ventricular tachyarrhythmia associated with cardiac sarcoidosis: its mechanisms and outcome","volume":"27","author":"Furushima","year":"2004","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib22","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.ijcard.2016.11.041","article-title":"Increased risk of ventricular tachycardia in patients with sarcoidosis during the very long term follow-up","volume":"228","author":"Te","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.005001","article-title":"Presence of late gadolinium enhancement by cardiac magnetic resonance among patients with suspected cardiac sarcoidosis is associated with adverse cardiovascular prognosis: a systematic review and meta-analysis","volume":"9","author":"Hulten","year":"2016","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2021.07.005_bib24","doi-asserted-by":"crossref","first-page":"e006145","DOI":"10.1161\/CIRCEP.117.006145","article-title":"Outcome of cardiac sarcoidosis presenting with high-grade atrioventricular block","volume":"11","author":"Nordenswan","year":"2018","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib25","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.hrthm.2012.02.010","article-title":"Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators","volume":"9","author":"Betensky","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.07.005_bib26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1540-8167.2012.02350.x","article-title":"Implantable cardioverter defibrillator therapy in patients with cardiac sarcoidosis","volume":"23","author":"Schuller","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/europace\/eus316","article-title":"Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"15","author":"Kron","year":"2013","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.07.005_bib28","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.003353","article-title":"Time course and factors correlating with ventricular tachyarrhythmias after introduction of steroid therapy in cardiac sarcoidosis","volume":"9","author":"Segawa","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib29","first-page":"1034","article-title":"Corticosteroid therapy for cardiac sarcoidosis: a systematic review","volume":"29","author":"Sadek","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021183","article-title":"Corticosteroid and immunosuppressant therapy for cardiac sarcoidosis: a systematic review","author":"Fazelpour","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2021.07.005_bib31","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/jce.13228","article-title":"Tailored approach for management of ventricular tachycardia in cardiac sarcoidosis","volume":"28","author":"Yalagudri","year":"2017","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/CIRCEP.113.000734","article-title":"Systematic treatment approach to ventricular tachycardia in cardiac sarcoidosis","volume":"7","author":"Naruse","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1161\/CIRCEP.114.002145","article-title":"Ventricular tachycardia in cardiac sarcoidosis: characterization of ventricular substrate and outcomes of catheter ablation","volume":"8","author":"Kumar","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib34","article-title":"Long-term outcome after catheter ablation of ventricular tachycardia in patients with nonischemic dilated cardiomyopathy","volume":"9","author":"Muser","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCEP.110.959957","article-title":"Endocardial unipolar voltage mapping to detect epicardial ventricular tachycardia substrate in patients with nonischemic left ventricular cardiomyopathy","volume":"4","author":"Hutchinson","year":"2011","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib36","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacep.2017.09.175","article-title":"Characterization of the electroanatomic substrate in cardiac sarcoidosis: correlation with imaging findings of scar and inflammation","volume":"4","author":"Muser","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib37","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0735-1097(02)02623-2","article-title":"Ablation of electrograms with an isolated, delayed component as treatment of unmappable monomorphic ventricular tachycardias in patients with structural heart disease","volume":"41","author":"Arenal","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib38","article-title":"Isolated cardiac sarcoidosis: establishing the diagnosis with electroanatomic mapping-guided endomyocardial biopsy","volume":"29","author":"Nery","year":"2013","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib39","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jchf.2014.03.015","article-title":"Electrogram guidance: a method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis","volume":"2","author":"Liang","year":"2014","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.hroo.2021.07.005_bib40","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1161\/01.CIR.101.11.1288","article-title":"Linear ablation lesions for control of unmappable ventricular tachycardia in patients with ischemic and nonischemic cardiomyopathy","volume":"101","author":"Marchlinski","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.07.005_bib41","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.hrthm.2019.03.014","article-title":"2019 HRS\/EHRA\/APHRS\/LAHRS expert consensus statement on catheter ablation of ventricular arrhythmias: executive summary","volume":"17","author":"Cronin","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.07.005_bib42","first-page":"822","article-title":"2020 Canadian Cardiovascular Society\/Canadian Heart Rhythm Society position statement on the management of ventricular tachycardia and fibrillation in patients with structural heart disease","volume":"36","author":"Deyell","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib43","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.hrcr.2015.01.018","article-title":"High-power bipolar ablation for incessant ventricular tachycardia utilizing a deep midmyocardial septal circuit","volume":"1","author":"Sauer","year":"2015","journal-title":"HeartRhythm Case Rep"},{"key":"10.1016\/j.hroo.2021.07.005_bib44","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1016\/j.hrthm.2020.04.028","article-title":"Acute and long-term results of bipolar radiofrequency catheter ablation of refractory ventricular arrhythmias of deep intramural origin","volume":"17","author":"Igarashi","year":"2020","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.07.005_bib45","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/europace\/eux277","article-title":"Treatment of intramural ventricular tachycardia in cardiac sarcoidosis with transcoronary ethanol ablation","volume":"19","author":"Markowitz","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.07.005_bib46","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/j.hrthm.2012.07.004","article-title":"Transvenous ethanol ablation of ventricular tachycardia","volume":"9","author":"Tedrow","year":"2012","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.07.005_bib47","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.hrthm.2018.09.010","article-title":"Retrograde venous ethanol ablation for ventricular tachycardia","volume":"16","author":"Tavares","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.07.005_bib48","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.jacep.2020.02.013","article-title":"Evaluation of radiofrequency ablation irrigation type: in\u00a0vivo comparison of normal versus half-normal saline lesion characteristics","volume":"6","author":"Tschabrunn","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib49","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jacep.2018.05.004","article-title":"Catheter ablation of mid-myocardial ventricular tachycardia by simultaneous unipolar radiofrequency ablation with half-normal saline irrigation","volume":"4","author":"Gaeta","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib50","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.jacc.2018.12.070","article-title":"Infusion needle radiofrequency ablation for treatment of refractory ventricular arrhythmias","volume":"73","author":"Stevenson","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib51","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/europace\/euz341","article-title":"Endocardial ventricular pulsed field ablation: a proof-of-concept preclinical evaluation","volume":"22","author":"Koruth","year":"2020","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.07.005_bib52","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.hrthm.2018.10.030","article-title":"Intracardiac pulsed field ablation: proof of feasibility in a chronic porcine model","volume":"16","author":"Stewart","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.07.005_bib53","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.hrthm.2019.02.025","article-title":"Cardiac sympathectomy for refractory ventricular arrhythmias in cardiac sarcoidosis","volume":"16","author":"Okada","year":"2019","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.07.005_bib54","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacep.2018.05.007","article-title":"Outcomes of catheter ablation of ventricular tachycardia based on etiology in nonischemic heart disease: an international ventricular tachycardia ablation center collaborative study","volume":"4","author":"Vaseghi","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib55","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1161\/CIRCEP.112.971341","article-title":"Catheter ablation of ventricular tachycardia in nonischemic heart disease","volume":"5","author":"Tokuda","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib56","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/europace\/eux077","article-title":"Catheter ablation for ventricular tachycardia in patients with cardiac sarcoidosis: a systematic review","volume":"20","author":"Papageorgiou","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2021.07.005_bib57","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/jce.14341","article-title":"Impact of the inflammation on the outcomes of catheter ablation of drug-refractory ventricular tachycardia in cardiac sarcoidosis","volume":"31","author":"Kaur","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib58","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1161\/CIRCULATIONAHA.106.686534","article-title":"Clinical perspective","volume":"117","author":"Carbucicchio","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.hroo.2021.07.005_bib59","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10554-005-9043-x","article-title":"Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia","volume":"22","author":"Futamatsu","year":"2006","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2021.07.005_bib60","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.ijcard.2016.10.101","article-title":"Impact of early initiation of corticosteroid therapy on cardiac function and rhythm in patients with cardiac sarcoidosis","volume":"227","author":"Padala","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib61","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1007\/s00259-018-4001-8","article-title":"Prognostic role of serial quantitative evaluation of (18)F-fluorodeoxyglucose uptake by PET\/CT in patients with cardiac sarcoidosis presenting with ventricular tachycardia","volume":"45","author":"Muser","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.hroo.2021.07.005_bib62","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.hrthm.2007.06.006","article-title":"Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis","volume":"4","author":"Banba","year":"2007","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.07.005_bib63","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1542-474X.2011.00418.x","article-title":"Effect of corticosteroid therapy on ventricular arrhythmias in patients with cardiac sarcoidosis","volume":"16","author":"Yodogawa","year":"2011","journal-title":"Ann Noninvasive Electrocardiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib64","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/jce.14689","article-title":"Treatment with corticosteroids is associated with an increase in ventricular arrhythmia burden in patients with clinically manifest cardiac sarcoidosis: insights from implantable cardioverter-defibrillator diagnostics","volume":"31","author":"Medor","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib65","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.jacep.2020.02.008","article-title":"Electroanatomical voltage mapping to distinguish right-sided cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Hoogendoorn","year":"2020","journal-title":"Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib66","article-title":"Long-term outcomes of catheter ablation of ventricular tachycardia in patients with cardiac sarcoidosis","volume":"9","author":"Muser","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib67","first-page":"210","article-title":"Ventricular tachycardia storm successfully treated with immunosuppression and catheter ablation in a patient with cardiac sarcoidosis","volume":"22","author":"Stees","year":"2011","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2021.07.005_bib68","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.117.007030","article-title":"Complementary value of cardiac magnetic resonance imaging and positron emission tomography\/computed tomography in the assessment of cardiac sarcoidosis","volume":"11","author":"Vita","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2021.07.005_bib69","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.hrthm.2012.10.019","article-title":"Electrophysiological characteristics of ventricular tachyarrhythmias in cardiac sarcoidosis versus arrhythmogenic right ventricular cardiomyopathy","volume":"10","author":"Dechering","year":"2013","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hroo.2021.07.005_bib70","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.amjcard.2009.03.068","article-title":"Comparison of necropsy findings in patients with sarcoidosis dying suddenly from cardiac sarcoidosis versus dying suddenly from other causes","volume":"104","author":"Tavora","year":"2009","journal-title":"Am J Cardiol"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501821001227?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501821001227?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:24:56Z","timestamp":1762993496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666501821001227"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":70,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2666501821001227"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2021.07.005","relation":{},"ISSN":["2666-5018"],"issn-type":[{"value":"2666-5018","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of ventricular tachycardia in patients with cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2021.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}